Lumito AB Quarterly Report (1 October to 31 December) 2019
Financial overview of the fourth quarter, 1 October – 31 December 2019 Result after taxes amounted to kSEK -2,545 (-2,148). Basic and diluted earnings per share amounted to SEK -0.04 (-0.08). Cash flow from operating activities amounted to kSEK -3,145 (-2,148). Financial overview of the year as a whole, 1 January – 31 December […]
Status update regarding the completion of Lumito’s first product
The development of Lumito’s first product (instrument + staining reagent) in digital tissue diagnostics, for analyzing tissue sections stained with the company’s nano-based staining reagents, is entering its final stage prior to launch. The development of the actual instrument is proceeding according to plan, and the first instruments, which are intended for customer validation at […]
Andreas Johansson – the new CTO
Andreas Johansson will take over as CTO on January 13, 2020, taking the place of Anders Sjögren who held this position since spring 2017. Anders remains in Lumito's organisation as a senior adviser and will continue to contribute to the company's development. – I look forward to starting as Lumito’s CTO. This is an innovative, […]
First exercise window for Lumito warrants closes
On 29 November, Lumito AB (publ) (“Lumito”) ended the first exercise period for the Series 2 TO2 subscription warrant. The exercise rate was 72.3 percent, at an exercise price of SEK 1.45 per share. In total, 11,179,281 new shares have been subscribed during the now concluded first exercise period. Lumito is thus provided approximately MSEK […]
Lumito – winner in the poster competition and awarded with a presentation at the Digital Pathology & AI Congress in London
Lumito has been selected by the conference committee as the winner of the poster competition and has been awarded a 15 min presentation at the Digital Pathology & AI Congress in London on 5-6 December. Lumito will be presented to over 420 attendees and 35 exhibitors at the sold out meeting. Krzysztof Krawczyk, R&D Manager […]
Lumito’s main owner, CEO and a member of the board exercise their subscription warrants in full
During the first exercise window, Lumito's major shareholder, Cardeon Futuring Finance (40 percent of which is owned by Masoud Khayyami), Lumito's CEO, Stefan Nilsson, and member of the board Ulf Bladin have exercised all of their Series TO2 warrants to subscribe for shares in Lumito AB. In total, this amounts to 2,130,000 subscription warrants. After the […]
Important progress in product development – simultaneous staining in the same section, with high degree of detail
Lumito is developing a novel method for high-contrast imaging without background signal. The first application is developed for tissue diagnostics and digital pathology. In order to visualize cells containing Her2, which is a common marker in breast cancer diagnostics, Lumito is now presenting new images of breast tissues stained with the Company's Her2-UCNP reagent. Lumito's […]
The alpha prototype of the instrument delivered to Lumito according to plan
Lumito’s development partner TTP has delivered the alpha prototype of what will be Lumito’s first product. After delivery, the instrument has successfully undergone internal acceptance testing. The ongoing development phase of Lumito’s first product includes the development of an alpha prototype, with essential functionality implemented (“work like”), and thereafter a beta prototype, with complete implementation […]
Last day of trading of Lumito TO1 subscription warrants
The last day of trading of Lumito AB (publ) TO1 is Wednesday, 3 July 2019. According to the terms and conditions for series Lumito TO1 subscription warrants, the subscription price shall be reassessed under certain conditions, such as when a preferential rights issue takes place during the warrant life of Lumito TO1. Since Lumito has […]
The last day of trading of paid subscription units (BTU)
The last day of trading of Lumito AB (publ) paid subscription units (BTU) is Tuesday, 2 July 2019. The preferential rights issue that was conducted during May/June 2019 has now been registered with the Swedish Companies Registration Office. The new shares and warrants (after conversion from paid subscription units) are expected to be delivered to […]
